The extent to which drug distributors and manufacturers pumped opioids into the U.S. was unknown to the public—until now. The government’s database, known as ARCOS, was […]

Hal Barron has detailed efforts to embolden GlaxoSmithKline scientists to take “smart risks” when developing drugs. The culture change is an effort to stop GSK researchers […]

Global venture capital funding for digital health companies in the first half of 2019 hit $5.1B with 318 deals, the highest amount raised in the first […]

DeepMind, the artificial-intelligence arm of Google’s parent Alphabet Inc., could transform how drugmakers discover and develop new medicines and put pressure on the world’s biggest pharma […]

According to a new Gallup poll, only 27% of Americans regard the pharmaceutical industry positively, compared with 58% who hold a negative view. This resulted in […]

Firm details on exactly how the U.K. will regulate new medicines is still to be decided after it leaves the EU later this year, but it […]

Recruiting strategies will need to continue evolving as the work demographic shifts and technology advances, but traditional companies may struggle to attract the best talent available. […]

Female CEOs remain exceedingly rare in the drug industry, accounting for less than 10% of biotech’s top leaders. A recent BioPharma Dive analysis of 180 leading […]

Regeneron is investing $800M in its New York operations to keep up with the growth of its flagship eye med Eylea and fast-launching immunology drug Dupixent. […]